Burden of influenza-associated respiratory and circulatory mortality in India, 2010-2013

Abstract

Burden of influenza-associated respiratory and circulatory mortality in India, 2010-2013 Background Influenza causes substantial morbidity and mortality worldwide, however, reliable burden estimates from developing countries are limited, including India. We aimed to quantify influenza-associated mortality for India utilizing 2010-2013 nationally representative data sources for influenza virus circulation and deaths. Methods Virological data were obtained from the influenza surveillance network of 10 laboratories led by National Institute of Virology, Pune covering eight states from 2010-2013. Death data were obtained from the nationally representative Sample Registration System for the same time period. Generalized linear regression with negative binomial distribution was used to model weekly respiratory and circulatory deaths by age group and proportion of specimens positive for influenza by subtype; excess deaths above the seasonal baseline were taken as an estimate of influenza-associated mortality counts and rates. Annual excess death rates and the 2011 India Census data were used to estimate national influenza-associated deaths. Results Estimated annual influenza-associated respiratory mortality rates were highest for those ≥65 years (51.1, 95% confidence interval (CI) = 9.2-93.0 deaths/100 000 population) followed by those <5 years (9.8, 95% CI = 0-21.8/100 000). Influenza-associated circulatory death rates were also higher among those ≥65 years (71.8, 95% CI = 7.9-135.8/100 000) as compared to those aged <65 years (1.9, 95% CI = 0-4.6/100 000). Across all age groups, a mean of 127 092 (95% CI = 64 046-190,139) annual influenza-associated respiratory and circulatory deaths may occur in India. Conclusions Estimated influenza-associated mortality in India was high among children <5 years and adults ≥65 years. These estimates may inform strategies for influenza prevention and control in India, such as possible vaccine introduction. Electronic supplementary material: The online version of this article contains supplementary material.

Influenza B infections in children: A review

“…They reported the median length of hospital stay of 3 d for IFB viral illness. An Indian study reported high influenza-associated mortality in children aged less than 5 years in addition to the elderly population[ 10 ]. Studies on the incidence, clinical burden, and economic impact of IFB helped to include an additional B strain in the vaccine against influenza.…”

Efficacy of live attenuated and inactivated influenza vaccines among children in rural India: A 2-year, randomized, triple-blind, placebo-controlled trial

“…Influenza causes significant pediatric mortality and morbidity globally, including in India [1][2][3]. Vaccines, including inactivated influenza vaccine (IIV) and live attenuated influenza vaccine (LAIV) formulations, are key to influenza prevention and control and have demonstrated moderate effectiveness when matched to circulating strains [4].…”

Awareness About Influenza and the Influenza Vaccine: A Doctor Survey to Assess Reasons for Influenza Vaccine Hesitancy in India

“…Hospitals and clinicians reported much more severe Influenza disease than they had seen previously and confirmed very high mortality rates [8]. Also, a study in 2013 reported that each year around 127,092 people die in India due to Influenza-associated respiratory and circulatory diseases [9]. WHO recommends the Influenza vaccine for high-risk groups such as pregnant women, children aged less than five years, the elderly, healthcare workers, and people who have chronic illnesses such as HIV/AIDS, asthma, diabetes, heart disease, or are immuno-compromised among others [10,11].…”